Introduction: Within the past decade, antiviral treatment for chronic hepatitis C virus (HCV)
infection has evolved from interferon (IFN)-based regimens to IFN-free oral direct-acting …

Abstract Background and Aim Few studies have evaluated sustained virological response
(SVR) rates by direct‐acting agents (DAAs) and liver stiffness measurement (LSM) changing …

BACKGROUND: A rapid decline of liver stiffness (LS) was detected by non-invasive
methods in patients with chronic hepatitis C (HCV) infection during treatment with direct …

Background The trajectory of liver fibrosis is not well understood in the contemporary era of
human immunodeficiency virus (HIV) and hepatitis C virus (HCV) therapy. Methods We …

Objective To assess changes in noninvasive liver fibrosis measurements after chronic
hepatitis C eradication by direct-acting antivirals in Egyptian adolescents. Study design Liver …

Objectives To assess the degree of liver stiffness using transient elastography in Egyptian
children infected with hepatitis C virus (HCV) at baseline and 1 year after achievement of …

Shear wave elastography (SWE) is a noninvasive ultrasound-based marker of hepatic
fibrosis not requiring a special device. Successful direct-acting anti-HCV therapy was …

Background Viral resistance-associated substitutions (RASs) can develop in the setting of
DAAs therapy (ie, emerging RASs). Long-term monitoring of fibrosis regression after …

Because of the prevalence of HCV worldwide as well as its undiagnosed population due to
a lack of screening, HCV can be considered a modern pandemic disease. In 2016, the …

Introduction. The severity of liver fibrosis can be assessed noninvasively today by liver
stiffness measurements. Vibration-controlled transient elastography, shear wave …